Our group has previously reported that the detection of CK-19 mRNA-positive CTC in the blood of patients with node-negative operable breast cancer before the initiation of any systemic treatment was an independent prognostic factor associated with an increased risk of disease recurrence [11]. The gene discussed is KRT19; the disease is breast cancer.